151096-09-2

GPTKB entity

Statements (38)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkbp:ATCCode none
gptkbp:bioavailability >60%
gptkbp:CASNumber gptkb:151096-09-2
gptkbp:clinicalTrialPhase Phase II
gptkbp:developedBy gptkb:Merck
gptkbp:drugClass recombinant human growth hormone
ghrelin receptor agonist
gptkbp:eliminationHalfLife 4-6 hours
gptkbp:excretion urine
gptkbp:hasInChIKey gptkb:QZJXODVYFRCQDF-UHFFFAOYSA-N
gptkbp:hasMolecularFormula C27H36N4O5S
gptkbp:hasSMILES CC(C)CN(C)CCCN1C=C(C2=CC=CC=C21)C(=O)NC3=CC=CC=C3S(=O)(=O)N
gptkbp:hasUNII JEV8U1C1YW
https://www.w3.org/2000/01/rdf-schema#label 151096-09-2
gptkbp:indication gptkb:bone
obesity
muscle wasting
growth hormone deficiency
gptkbp:isNotApprovedBy gptkb:FDA
gptkb:EMA
gptkbp:legalStatus investigational
gptkbp:mechanismOfAction stimulates growth hormone release
ghrelin receptor agonist
gptkbp:metabolism liver
gptkbp:molecularWeight 528.7 g/mol
gptkbp:PubChem_CID gptkb:CHEMBL122931
gptkb:DB12189
159633
gptkbp:routeOfAdministration oral
gptkbp:sideEffect muscle pain
increased appetite
elevated blood sugar
transient edema
gptkbp:synonym gptkb:Ibutamoren
gptkb:MK-677
gptkbp:bfsParent gptkb:Avelox
gptkbp:bfsLayer 5